Increased plasma budesonide concentrations in late-stage PBC may be associated with serious adverse events

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1399, 2003-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-label Vistide use associated with serious adverse events

Reactions Weekly, Vol. 1, Iss. 1338, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Serious adverse events reported with trastuzumab

Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Serious adverse CV events with varenicline

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A meta-analysis has identified a significantly increased risk of serious adverse events and treatment discontinuation in patients receiving telaprevir

Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite